| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT06618235 | Trial of THEO-260 in Ovarian Cancer Patients | Ovarian Cancer | Recruiting |
| Phase 1 | |||
| NCT07211659 | Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients | Ovarian Cancer | Recruiting |